
    
      This multi-center, prospective, single arm study will include up to 100 patients (20-40
      patients per site), aimed at evaluating the performance of the Pure-Vu System in cleansing
      hospitalized patients' colon who are indicated for standard colonoscopy procedure.

      Subjects will be enrolled at up to 4 clinical sites in the United States and Europe. Subjects
      who meet the eligibility criteria will be prescribed a standard bowel preparation bowel
      preparation regimen including diet restrictions and oral bowel preparation.

      Following the bowel preparation, the patient will undergo colonoscopy with the Pure-Vu
      system.

      In case of inadequate bowel preparation, as per the nurse report and / or BBPS < 2, in at
      least one of the colon segments, prior Pure-Vu use, the physician will complete a
      questionnaire on the patient's management standard of care assuming the absence of Pure-Vu.

      Follow-up will be conducted at 48 hours (Â± 48 hours) post procedure.
    
  